Skip to main content

Cardiol Therapeutics Inc(CRDL-T)
TSX

Today's Change
Real-Time Last Update
Volume

Latest News

Stocks in play: Cardiol Therapeutics Inc.
Baystreet - Tue Mar 22, 8:52AM CDT
Baystreet
Tue Mar 22, 8:52AM CDT
Announced today that Cardiol's Chief Medical Officer, Dr. Andrew Hamer, will be participating in a panel ...
Cardiol Announces Upsize to Previously Announced Bought Deal Public Offering
Globe NewsWire - Thu May 6, 2021
Globe NewsWire
Thu May 6, 2021
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES NOR FOR DISSEMINATION IN THE UNITED STATES
Cardiol Therapeutics Announces $15 Million Bought Deal Public Offering
Globe NewsWire - Wed May 5, 2021
Globe NewsWire
Wed May 5, 2021
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND  IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE  SERVICES NOR FOR DISSEMINATION IN THE UNITED STATES.
Virtual Conference for Life Sciences Companies Broadcast Live September 17th, 2020
Globe NewsWire - Mon Sep 14, 2020
Globe NewsWire
Mon Sep 14, 2020
Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com
CannabisNewsBreaks – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) to Secure $11.25 Million in Bought Deal Public Offering
Investor Brand Network - Tue Jun 2, 2020
Investor Brand Network
Tue Jun 2, 2020
Cardiol Therapeutics (TSX: CRDL) (OTCQX: CRTPF), a leader in the production of pharmaceutical cannabidiol (“CBD”) and the development of innovative cannabidiol products for heart diseases, recently announced its entry into an agreement with...